Clinical Trials in Baltimore

Showing 1261-1280 of 23,476 trials

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

NCT06284486

To learn if the combination of venetoclax and revumenib can help to control MRD-positive AML.

M.D. Anderson Cancer Center8 participantsStarted Sep 2024

Baltimore, Maryland, United States • Boston, Massachusetts, United States • New York, New York, United States +1 more locations

RECRUITINGPhase 1< 1 mile

The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles

NCT05602649

This study will examine the pharmacokinetics and pharmacodynamics of delta-9-tetrahydrocannabinol (THC)-infused chocolates, gummies, and drinks. Healthy adults (N=40) will complete 9 drug administration sessions, including an overnight stay prior to each session. Participants will consume THC containing products in a fasted state; following drug administration, the participants will complete cognitive and psychomotor tasks, subjective assessments, have blood collected, and vital signs monitored.

Cannabis Use

Johns Hopkins University80 participantsStarted Jul 2024

Baltimore, Maryland, United States

RECRUITINGNA< 1 mile

mPATH for Low-income Older Adults

NCT05935241

Although empirical research suggests that physical activity interventions benefit cognition and sleep in older adults in general, the possible benefit of physical activity is understudied in low-income older adults. The study aims to test the immediate and sustaining efficacy of an mHealth-facilitated Physical Activity Toward Health (mPATH) intervention on cognitive function and sleep in low-income older adults.

Sedentary TimeInsomniaCognitive Decline

Johns Hopkins University176 participantsStarted May 2024

Baltimore, Maryland, United States

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles

mPATH for Low-income Older Adults

Find Trials by Condition in Baltimore

Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)

Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor

A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery

Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)

Lurbinectedin + Doxorubicin In Leiomyosarcoma

A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)

Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC